Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Radaelli

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 26, 2015
Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosisMarco Fiore, Chiara Colombo, Stefano Radaelli, et al.
Annals of Surgical Oncology|March 17, 2023
Organ Infiltration and Patient Risk After Multivisceral Surgery for Primary Retroperitoneal LiposarcomasLuca Improta, Sandro Pasquali, Sara Iadecola, et al.
Annals of Surgical Oncology|July 8, 2020
Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral InstitutionAndraz Perhavec, Salvatore Provenzano, Marco Baia, et al.
Annals of Surgical Oncology|July 26, 2024
Surgical Outcome in Retroperitoneal Sarcoma Surgery: Accuracy of P-POSSUM, ACS-NSQIP, and Inflammatory Biomarkers Prognostic Index (IBPI) Risk-Calculators for Prediction of Severe and Overall MorbidityMichela Angelucci, Marco Baia, Marilù Garo, et al.
Journal of Surgical Oncology|December 17, 2018
Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients-A propensity score analysisEran Nizri, Marco Fiore, Chiara Colombo, et al.
Spine|April 8, 2016
Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference CentersStefano Radaelli, Silvia Stacchiotti, Pietro Ruggieri, et al.
Annals of Surgical Oncology|January 29, 2021
Unplanned Excision of Extremity and Trunk Wall Soft Tissue Sarcoma: To Re-resect or Not to Re-resect?Maria Danieli, Francesco Barretta, Marco Fiore, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 14, 2022
Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohortStefano Radaelli, Sandro Pasquali, Chiara Colombo, et al.
Annals of Surgical Oncology|November 11, 2020
A Prospective Observational Study of Multivisceral Resection for Retroperitoneal Sarcoma: Clinical and Patient-Reported Outcomes 1 Year After SurgeryMarco Fiore, Cinzia Brunelli, Rosalba Miceli, et al.
JAMA Surgery|February 23, 2022
Residual Adrenal Function After Multivisceral Resection With Adrenalectomy in Adult PatientsMarco Fiore, Marco Baia, Lorenzo Conti, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|November 26, 2015
Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosisMarco Fiore, Chiara Colombo, Stefano Radaelli, et al.
Annals of Surgical Oncology|March 17, 2023
Organ Infiltration and Patient Risk After Multivisceral Surgery for Primary Retroperitoneal LiposarcomasLuca Improta, Sandro Pasquali, Sara Iadecola, et al.
Annals of Surgical Oncology|July 8, 2020
Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral InstitutionAndraz Perhavec, Salvatore Provenzano, Marco Baia, et al.
Annals of Surgical Oncology|July 26, 2024
Surgical Outcome in Retroperitoneal Sarcoma Surgery: Accuracy of P-POSSUM, ACS-NSQIP, and Inflammatory Biomarkers Prognostic Index (IBPI) Risk-Calculators for Prediction of Severe and Overall MorbidityMichela Angelucci, Marco Baia, Marilù Garo, et al.
Journal of Surgical Oncology|December 17, 2018
Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients-A propensity score analysisEran Nizri, Marco Fiore, Chiara Colombo, et al.
Spine|April 8, 2016
Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference CentersStefano Radaelli, Silvia Stacchiotti, Pietro Ruggieri, et al.
Annals of Surgical Oncology|January 29, 2021
Unplanned Excision of Extremity and Trunk Wall Soft Tissue Sarcoma: To Re-resect or Not to Re-resect?Maria Danieli, Francesco Barretta, Marco Fiore, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 14, 2022
Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohortStefano Radaelli, Sandro Pasquali, Chiara Colombo, et al.
Annals of Surgical Oncology|November 11, 2020
A Prospective Observational Study of Multivisceral Resection for Retroperitoneal Sarcoma: Clinical and Patient-Reported Outcomes 1 Year After SurgeryMarco Fiore, Cinzia Brunelli, Rosalba Miceli, et al.
JAMA Surgery|February 23, 2022
Residual Adrenal Function After Multivisceral Resection With Adrenalectomy in Adult PatientsMarco Fiore, Marco Baia, Lorenzo Conti, et al.
Pageof 6